Anhui Hongyu Wuzhou Medical Manufacturer Co (301234) Fair Value & Analysis
Healthcare · CN · Market cap 2.5B CNY
Fair value as of: Jun 24, 2026
Analysis
Anhui Hongyu Wuzhou Medical Manufacturer Co (301234) currently trades at ¥37.41, while our model-based Fair Value estimate is ¥6.11 — implying the stock looks roughly 83.7% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Anhui Hongyu Wuzhou Medical Manufacturer Co.,Ltd. engages in the research, development, production, and sale of disposable sterile infusion medical devices in China. It offers disposable syringes, infusion (blood) devices, puncture needles, hypodermic needles, blood collection needles and sets, conventional syringes, and insulin syringes and pen needles, as well as infusion, blood administration, burette, and scalp vein sets. The company also exports its products to approximately 80 countries. The company was founded in 2011 and is based in Anqing, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Anhui Hongyu Wuzhou Medical Manufacturer Co (301234) undervalued?
What is the fair value of 301234?
What is the quality score of 301234?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.